Last Updated: October 4, 2026

EPOPROSTENOL Drug Patent Profile

Name: EPOPROSTENOL Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Epoprostenol patents expire, and what generic alternatives are available?

Epoprostenol is a drug marketed by Gland, Meitheal, Mylan, and Sun Pharm. and is included in four NDAs.

The generic ingredient in EPOPROSTENOL is epoprostenol sodium. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the epoprostenol sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Epoprostenol

A generic version of EPOPROSTENOL was approved as epoprostenol sodium by SUN PHARM on January 15^th, 2021.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for EPOPROSTENOL?
What are the global sales for EPOPROSTENOL?
What is Average Wholesale Price for EPOPROSTENOL?

Summary for EPOPROSTENOL

US Patents:	0
Applicants:	4
NDAs:	4
Drug Prices:	Drug price information for EPOPROSTENOL
DailyMed Link:	EPOPROSTENOL at DailyMed

Drug patent expirations by year for EPOPROSTENOL

US Patents and Regulatory Information for EPOPROSTENOL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Gland	EPOPROSTENOL SODIUM	epoprostenol sodium	INJECTABLE;INJECTION	219237-001	Dec 29, 2025	AP2	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sun Pharm	EPOPROSTENOL SODIUM	epoprostenol sodium	INJECTABLE;INJECTION	210473-001	Jan 15, 2021	AP2	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Meitheal	EPOPROSTENOL SODIUM	epoprostenol sodium	INJECTABLE;INJECTION	078396-002	Apr 23, 2008		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for EPOPROSTENOL

Epoprostenol cost?
Epoprostenol sodium api?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.